Intended for healthcare professionals


WHO recommends additional tests for Sanofi’s dengue vaccine after safety concerns

BMJ 2018; 361 doi: (Published 20 April 2018) Cite this as: BMJ 2018;361:k1765
  1. Gareth Iacobucci
  1. The BMJ

Sanofi Pasteur’s vaccine against dengue fever should be used only by people already infected with the virus, subject to additional testing, the World Health Organization has said.

The updated recommendations of WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) on the use of Dengvaxia were made on 19 April after a meeting in Geneva, Switzerland.

The move follows the disclosure of new data by Sanofi …

View Full Text

Log in

Log in through your institution


* For online subscription